Dipeptidyl Peptidase 4 Inhibitor

Established Pharmacologic Class (EPC) Comparison, United States, 2017

Total Prescriptions in (2017)

Drug Name Total Prescriptions (2017) Percent Share
Sitagliptin Phosphate 8,485,404 49.6%
Metformin Hydrochloride; Sitagliptin Phosphate 4,735,730 27.7%
Linagliptin 2,823,706 16.5%
Saxagliptin Hydrochloride 1,054,309 6.2%

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2007-2017. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 20.1. Read more about the ClinCalc DrugStats database.


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

RxHero - Gamified learning for the Top 250 Drugs
©2020 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top